KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $260.68 $288.54 Thursday, 25th Apr 2024 AMGN stock ended at $269.38. This is 1.33% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.66% from a day low at $267.24 to a day high of $274.35.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Oct 25, 2023 $275.09 $276.69 $272.10 $272.16 2 164 638
Oct 24, 2023 $272.09 $277.06 $271.13 $276.12 2 133 258
Oct 23, 2023 $280.12 $280.12 $272.71 $273.06 2 251 912
Oct 20, 2023 $280.60 $281.06 $275.76 $278.81 2 236 270
Oct 19, 2023 $282.09 $283.20 $278.10 $280.60 2 410 350
Oct 18, 2023 $283.30 $285.25 $281.02 $283.58 2 701 917
Oct 17, 2023 $285.19 $287.34 $282.62 $284.42 2 738 556
Oct 16, 2023 $284.50 $287.81 $283.81 $286.88 2 366 019
Oct 13, 2023 $287.70 $288.46 $280.00 $284.10 3 347 408
Oct 12, 2023 $283.98 $287.85 $283.60 $285.04 3 010 198
Oct 11, 2023 $274.86 $284.33 $274.15 $283.60 4 349 040
Oct 10, 2023 $270.89 $272.06 $268.12 $271.25 1 651 242
Oct 09, 2023 $271.04 $272.60 $268.58 $271.54 2 199 869
Oct 06, 2023 $263.15 $268.59 $262.23 $267.47 2 663 256
Oct 05, 2023 $266.19 $267.92 $262.54 $265.08 2 476 198
Oct 04, 2023 $262.10 $266.14 $260.91 $265.44 2 393 350
Oct 03, 2023 $264.04 $266.03 $259.67 $261.01 2 606 214
Oct 02, 2023 $267.71 $268.49 $264.38 $266.31 1 769 724
Sep 29, 2023 $271.00 $271.00 $267.22 $268.76 1 944 157
Sep 28, 2023 $267.79 $271.38 $266.54 $270.82 2 423 580
Sep 27, 2023 $271.73 $273.61 $266.76 $268.98 2 184 618
Sep 26, 2023 $266.68 $269.89 $265.67 $269.04 2 227 503
Sep 25, 2023 $267.54 $267.81 $265.01 $266.86 1 463 398
Sep 22, 2023 $267.67 $269.50 $266.56 $267.70 1 696 497
Sep 21, 2023 $272.07 $272.48 $267.70 $269.41 2 353 062
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT